Immune Therapeutics, Inc.
Immune Therapeutics, Inc. (IMUN) stock FAQs
Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.
What is Immune Therapeutics, Inc. (IMUN) stock price today?
As of Oct 18, 2023, 4:27 PM UTC, Immune Therapeutics, Inc. (IMUN) stock is trading at $0.093. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date IMUN stock quotes for informed trading decisions.
What is Immune Therapeutics, Inc.'s market capitalization?
Immune Therapeutics, Inc. (IMUN) has a market capitalization of approximately $7.8M. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Immune Therapeutics, Inc.'s size relative to other companies in the USD market. The market cap figure updates automatically as the IMUN stock price changes.
What is the 52-week range for Immune Therapeutics, Inc. stock?
Immune Therapeutics, Inc. (IMUN) stock has traded in a 52-week range of $0.0668 — $1.30. The 52-week range shows the highest and lowest prices at which IMUN traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Immune Therapeutics, Inc. stock price to this range provides context for recent price action.
How much trading volume does Immune Therapeutics, Inc. stock have?
Immune Therapeutics, Inc. (IMUN) stock recently traded approximately 1.8K shares. Trading volume indicates market liquidity and investor interest in IMUN. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Immune Therapeutics, Inc. stock.
Does Immune Therapeutics, Inc. pay dividends to shareholders?
Yes, Immune Therapeutics, Inc. (IMUN) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Immune Therapeutics, Inc. stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.
What is Immune Therapeutics, Inc.'s intraday price range?
Today, Immune Therapeutics, Inc. (IMUN) stock has traded in a range of $0.093 — $0.093. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring IMUN's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.
Where does AlphaPilot get Immune Therapeutics, Inc. stock data?
AlphaPilot sources real-time IMUN stock quotes, fundamental financial data, and historical price charts for Immune Therapeutics, Inc. from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Immune Therapeutics, Inc. stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of IMUN stock performance.